IL1B and colitis: Others also demonstrate that inhibiting ILK abrogates NLRP3-mediated IL-1β production [68], that ILK knockdown reduces TNF-α production via NF-κB [69], and that ILK knockout in intestinal epithelial or myeloid cells reduces DSS-induced colitis in mice [70,71].